Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23197230)

1.

Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver.

Bae SK, Yatsuhashi H, Hashimoto S, Motoyoshi Y, Ozawa E, Nagaoka S, Abiru S, Komori A, Migita K, Nakamura M, Ito M, Miyakawa Y, Ishibashi H.

Med Sci Monit. 2012 Dec;18(12):CR698-705.

2.

Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children.

Wu JF, Su YR, Chen CH, Chen HL, Ni YH, Hsu HY, Wang JL, Chang MH.

J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):97-100. doi: 10.1097/MPG.0b013e31822a033e.

3.

Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.

Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

Gastroenterology. 2009 Feb;136(2):505-12. doi: 10.1053/j.gastro.2008.10.089. Epub 2008 Nov 27.

PMID:
19101558
4.

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.

Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA.

Hepatology. 2010 Jun;51(6):1933-44. doi: 10.1002/hep.23571.

PMID:
20512987
5.

Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.

Huang YH, Hung HH, Chan CC, Lai CR, Chu CJ, Huo TI, Lee PC, Su CW, Lan KH, Huang HC, Lee IC, Lin HC, Lee SD.

Clin Vaccine Immunol. 2010 Jun;17(6):1048-53. doi: 10.1128/CVI.00460-09. Epub 2010 Apr 28.

6.

Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-year prospective study.

Lu H, Geng da Y, Shen F, Zhang JY, Lu B, Ma LX.

Virol J. 2011 Sep 21;8:444. doi: 10.1186/1743-422X-8-444.

7.

Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.

Takkenberg B, Terpstra V, Zaaijer H, Weegink C, Dijkgraaf M, Jansen P, Beld M, Reesink H.

J Gastroenterol Hepatol. 2011 Oct;26(10):1527-35. doi: 10.1111/j.1440-1746.2011.06766.x.

PMID:
21557773
8.

Effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men.

Wu JF, Tsai WY, Hsu HY, Ni YH, Chen HL, Tsuei DJ, Chang MH.

Gastroenterology. 2010 Mar;138(3):942-8.e1. doi: 10.1053/j.gastro.2009.11.051. Epub 2009 Dec 4.

PMID:
19962986
9.

Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.

Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ.

Hepatology. 2007 Oct;46(4):1057-70.

PMID:
17654702
10.

The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.

Fung J, Lai CL, Tanaka Y, Mizokami M, Yuen J, Wong DK, Yuen MF.

Am J Gastroenterol. 2009 Aug;104(8):1940-6; quiz 1947. doi: 10.1038/ajg.2009.200. Epub 2009 May 19.

PMID:
19455108
11.

Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection.

Tseng YR, Wu JF, Ni YH, Chen HL, Chen CC, Wen WH, Hsu HY, Chang MH.

Liver Int. 2011 Oct;31(9):1373-80. doi: 10.1111/j.1478-3231.2011.02574.x. Epub 2011 Jun 28.

PMID:
21745315
12.

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

Tseng TC, Liu CJ, Chen CL, Wang CC, Su TH, Kuo SF, Chen PJ, Chen DS, Kao JH.

J Infect Dis. 2012 Jan 1;205(1):54-63. doi: 10.1093/infdis/jir687. Epub 2011 Nov 17.

13.

Influence of age and HBeAg status on the correlation between HBV DNA and hepatic inflammation and fibrosis in chronic hepatitis B patients.

Bai H, Liu H, Chen X, Xu C, Dou X.

Dig Dis Sci. 2013 May;58(5):1355-62. doi: 10.1007/s10620-012-2479-7. Epub 2012 Nov 22.

PMID:
23179154
14.

[Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].

Liu SQ, Zhu XJ, Sun XH, Li M, Gao YQ.

Zhonghua Gan Zang Bing Za Zhi. 2012 May;20(5):348-52. doi: 10.3760/cma.j.issn.1007-3418.2012.05.009. Chinese.

PMID:
22971279
15.

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients.

Wang CC, Liu CJ, Lai MY, Kao JH, Chen DS.

Liver Int. 2007 Mar;27(2):235-9.

PMID:
17311619
16.

A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.

Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS.

Liver Int. 2008 Aug;28(7):1034-41. doi: 10.1111/j.1478-3231.2008.01766.x. Epub 2008 May 19.

PMID:
18492018
17.

Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.

Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.

Liver Int. 2007 Aug;27(6):806-15.

PMID:
17617124
18.

[Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].

Ying RS, Yang Z, Chen YY, Yang KL, Xiao YH, Wu LJ, Fan HM.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):585-8. doi: 10.3760/cma.j.issn.1007-3418.2012.08.009. Chinese.

PMID:
23207151
19.

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.

Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH.

Antivir Ther. 2011;16(5):629-37. doi: 10.3851/IMP1841.

PMID:
21817184
20.

[Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].

Zhou HJ, Li SG, Wen FY, Yang XY, Wu JL, Tan B, Fu J.

Zhonghua Gan Zang Bing Za Zhi. 2009 Aug;17(8):564-8. Chinese.

PMID:
19719911
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk